Quadex Pharmaceuticals, LLC
Records under this name other than the patents Quadex Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to Quadex Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,125,911 | Combined systemic and topical treatment of disordered tissues Lapsed on the fee record Ended Sep 8, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2023 | From the USPTO record |
| US 8,846,725 | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues Lapsed on the fee record Ended Sep 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2022 | From the USPTO record |
| US 9,549,930 | Combined systemic and topical treatment of disordered and/or prodromal stage tissue Lapsed on the fee record Ended Jan 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 24, 2021 | From the USPTO record |
| US 9,545,408 | Combined systemic and topical treatment of disordered tissues Lapsed on the fee record Ended Jan 17, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2021 | From the USPTO record |
| US 9,463,180 | Treatment of molluscum contagiosum Lapsed on the fee record Ended Oct 11, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 11, 2020 | From the USPTO record |
| US 8,173,709 | Anti-Infective Methods for Treating Pathogen-Induced Disordered Tissues Formerly held Lapsed on the fee record Ended May 8, 2020 · Low confidence | Lapsed on the fee record | Ended May 8, 2020 | Low confidence |
| US 6,211,243 | Methods for treating cold sores with anti-infective compositions Formerly held Term ended Term ended Sep 22, 2019 · From the USPTO record | Term ended | Term ended Sep 22, 2019 | From the USPTO record |
| US 6,410,599 | Antiseptic Compositions Suitable for Application to Human Tissue Formerly held Term ended Ended no later than Sep 22, 2019 · Low confidence | Term ended | Ended no later than Sep 22, 2019 | Low confidence |
| US 6,414,032 | Anti-infective compositions for treating disordered tissue such as cold sores Formerly held Term ended Term ended Sep 22, 2019 · From the USPTO record | Term ended | Term ended Sep 22, 2019 | From the USPTO record |
| US 6,420,431 | Methods for treating disordered tissue through agitated delivery of anti-infective compositions Formerly held Term ended Term ended Sep 22, 2019 · From the USPTO record | Term ended | Term ended Sep 22, 2019 | From the USPTO record |